UFC releases statement on Anderson Silva’s failed drug test

The Ultimate Fighting Championship just released the following statement in regards to Anderson Silva testing positive for Drostanolone metaboblities, an anabolic steroid, ahead of his UFC 183 bout with Nick Diaz:

On February 3, 2015, the UFC organization was notified by the Nevada State Athletic Commission that Anderson Silva tested positive for Drostanolone metabolites on his Jan. 9 out of competition drug test. UFC’s understanding is that further testing will be conducted by the Commission to confirm these preliminary results.

“Anderson Silva has been an amazing champion and a true ambassador of the sport of mixed martial arts and the UFC, in Brazil as well as around the world. UFC is disappointed to learn of these initial results.

“The UFC has a strict, consistent policy against the use of any illegal and/or performance enhancing drugs, stimulants or masking agents by its athletes.

This means that Silva’s victory over Nick Diaz this past Saturday night will likely be turned into a NC and Silva could even be suspended. After a highly emotional comeback this comes as disappointing news. It’s a shame that steroids and street drugs have clouded the last two high-profile UFC PPV’s which have featured arguably the two greatest P4P fighters to ever live. We’ll have much more on this story in the coming days. It is truly another dark day for the sport.

UPDATE: Nick Diaz also failed a drug test, his of the post-fight variety, for marijuana metabolites. This comes as no surprise.

Anderson Silva AND Nick Diaz fail drug tests … Silva’s failure was on a PRE-FIGHT test. Diaz post-fight test for marijuana. Story coming

— Kevin Iole (@KevinI) February 4, 2015